Table 2.
Significantly good imaging parameters in ROC analysis
| Area under ROC curve | 95% CI | P | |
|---|---|---|---|
| Pretreatment 18F-FDG PET | |||
| Short runs emphasis (SRE) | 0.75 | 0.32-0.68 | 0.006 |
| Long runs emphasis (LRE) | 0.75 | 0.60-0.91 | 0.005 |
| Gray-level nonuniformity (GLNU)* | 0.76 | 0.56-0.88 | 0.005 |
| Large zones emphasis (LZE) | 0.76 | 0.60-0.91 | 0.004 |
| 2nd-week 18F-FDG PET | |||
| ∆SUVmax | 0.75 | 0.56-0.89 | 0.006 |
| ∆MTV | 0.77 | 0.66-0.93 | 0.004 |
| ∆TLG | 0.81 | 0.62-0.92 | 0.001 |
| ∆Run length nonuniformity (RLNU) | 0.75 | 0.61-0.91 | 0.006 |
| ∆Gray-level nonuniformity (GLNU)† | 0.77 | 0.61-0.91 | 0.003 |
ROC receiver operating characteristic, SUVmax maximum standardized uptake value, MTV metabolic tumor volume, TLG total lesion glycolysis.
Derived from grey level run length encoding method.
Derived from grey-level size zone matrix.